Allcutis Research, Llc

Beverly, Massachusetts 01915

0 studies enrolling now · 10 studies all time

What they study most

Alopecia, Atopic Dermatitis, Basal Cell Carcinoma, Male Pattern Hair Loss, Malignant Skin Melanoma T0, NonSegmental Vitiligo, Plaque Psoriasis, Prurigo Nodularis, Pruritis, Psoriasis, Skin Diseases, Squamous Cell Carcinoma

Studies at this site

• A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1) — Running, not enrolling
• Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis — Completed
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed
• Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) — Completed
• A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis — Completed
• Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis — Completed
• Study to Assess the Efficacy and Safety of Orismilast in Psoriasis — Completed
• A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis — Completed
• To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia — Completed
• DERM US and EU Validation Study — Completed